Skip to main content
Log in

Grass allergen tablets improve QOL in rhinoconjunctivitis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Rak S, Yang WH, Pedersen MR, Durham SR.Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study. Quality of Life Research 16: 191-201, No. 2, Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grass allergen tablets improve QOL in rhinoconjunctivitis. Pharmacoecon. Outcomes News 522, 9 (2007). https://doi.org/10.2165/00151234-200705220-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705220-00026

Keywords

Navigation